Analyst consensus rating
MIRA Pharmaceuticals Analyst Rating: none
Direct answer
MIRA Pharmaceuticals's consensus rating is none.
1 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $3.50.
Forecast evidence checked October 7, 2026.
Get free MIRA Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.70
- Average price target
- $3.50
- High price target
- $3.50
- Low price target
- $3.50
- Low target gap
- +397.8%
- Target upside
- +397.8%
- High target gap
- +397.8%
- Target range width
- 0%
- Consensus rating
- none
- Analysts
- 1
- Evidence date
- October 7, 2026
- Valid through
- October 14, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for MIRA Pharmaceuticals?
MIRA Pharmaceuticals has a verified none consensus. The same dataset has an average price target of $3.50.
How far are MIRA Pharmaceuticals's low and high targets from the recorded price?
The low target implies +397.8%, while the high target implies +397.8%.
How many analysts are included in MIRA Pharmaceuticals's consensus?
The verified consensus includes 1 analysts.
How is MIRA Pharmaceuticals's target upside or downside calculated?
The average target of $3.50 is divided by the recorded price of $0.70, then one is subtracted to produce +397.8%. This does not guarantee a future return.
When was MIRA Pharmaceuticals's analyst forecast verified?
The data was verified on 2026-10-07. The dataset is valid through 2026-10-14.